NanoCytomics is a Medical Device company working on commercializing a novel medical imaging technique to screen different types of cancers including lung and colon cancer. The company has licensed the technology that was developed by the co-founders at Northwestern University and Northshore University HealthSystems. The company's technology platform provides accurate, low-cost, non-invasive testing to improve the risk stratification of patients. This technology will help physicians identify people that are likely to benefit from gold-standard procedures to diagnose cancer as early as possible, when treatments are most likely to be effective.
